Medical Developments International Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Medical Developments International Stock Forecast and Price Target
The average price target for Medical Developments International's stock of $3.03 recently provided by leading analysts would represent a 558.7% upside from its last closing price if reached. This potential increase is based on a high estimate of $3.03 and a low estimate of $3.03. You may be interested in rivals even if you aren't interested in Medical Developments International stock.
558.70% Upside
Medical Developments International Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Medical Developments International's Price has gone down from $0.66 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $0.47 – an increase of 100.00%. For the next eight years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CU6 Stock Forecast | Clarity Pharmaceuticals Ltd | Buy |
2
|
$3.01 | Buy/Sell | $2.00 | 3.65% |
| MYX Stock Forecast | Mayne Pharma Group | Buy |
11
|
$6.80 | Buy/Sell | $3.90 | 3.53% |
| PBP Stock Forecast | Probiotec | Hold |
17
|
$2.86 | Buy/Sell | $3.15 | 4.90% |
| VLS Stock Forecast | Vita Life Sciences | - |
0
|
$2.29 | Buy/Sell | $0.85 | -100.00% |
| IXHL Stock Forecast | Incannex Healthcare | - |
6
|
$2.67 | Buy/Sell | $73.15 | -100.00% |
Medical Developments International Revenue Forecast for 2023 - 2025 - 2030
Medical Developments International's Revenue has seen growth In the last three years, going from $22.54M to $32.34M – a gain of 43.48% In the next year, analysts believe that Revenue will reach $37.60M – an increase of 16.26%. For the next eight years, the forecast is forRevenue to grow by 85.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PAA Stock Forecast | PharmAust | - |
5
|
$0.23 | Buy/Sell | $0.00 | -100.00% |
| ANP Stock Forecast | Antisense Therapeutics | Buy |
0
|
$0.07 | Buy/Sell | $0.27 | 257.14% |
| LGP Stock Forecast | Little Green Pharma Ltd | Hold |
7
|
$0.13 | Buy/Sell | $0.28 | 30.77% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IDT Stock Forecast | IDT Australia | - |
0
|
$0.11 | Buy/Sell | $0.00 | -100.00% |
| CAN Stock Forecast | Cann Group | - |
0
|
$0.06 | Buy/Sell | $1.12 | -100.00% |
| KZIA Stock Forecast | Kazia Therapeutics |
6
|
$0.35 | Buy/Sell | $0.30 | -48.57% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EOF Stock Forecast | Ecofibre | - |
6
|
$0.07 | Buy/Sell | $1.14 | -100.00% |
| SNT Stock Forecast | Syntara |
2
|
$0.02 | Buy/Sell | $0.34 | 900.00% | |
| ACR Stock Forecast | Acrux |
0
|
$0.06 | Buy/Sell | $0.25 | 316.67% |
Medical Developments International EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Medical Developments International's EBITDA has decreased by 529.46%, going from $3.70M to $-15.89M. 1 analysts predict Medical Developments International's EBITDA will decrease by 38.33% in the next year, reaching $-9.80M. By 2030, professionals predict that Medical Developments International's EBITDA will decrease by 206.99%, to $17.00M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IXC Stock Forecast | Invex Therapeutics Ltd | - |
0
|
$0.08 | Buy/Sell | $0.00 | -100.00% |
| AGH Stock Forecast | Althea Group Holdings | - |
6
|
$0.04 | Buy/Sell | $0.00 | -100.00% |
| EMD Stock Forecast | Emyria | - |
0
|
$0.05 | Buy/Sell | $0.18 | -100.00% |
Medical Developments International EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Medical Developments International's EBIT has decreased from $2.44M to $-17.30M – a 809.02% drop. For the following year, the 1 analysts predict that Medical Developments International's EBIT will drop by 23.12%, reaching $-13.30M. In 2030, the professionals' prediction is that MVP's EBIT will decrease by 107.59%, reaching $1.31M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BXN Stock Forecast | Bioxyne | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| MDC Stock Forecast | Medlab Clinical | - |
0
|
$6.60 | Buy/Sell | $18.84 | -100.00% |
| AVE Stock Forecast | Avecho Biotechnology | - |
0
|
$0.00 | Buy/Sell | $0.09 | 0.00% |
Medical Developments International EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Medical Developments International's EPS has gone down from $0.01 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $-0.20 – an increase of 100.00%. For the next eight years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ZLD Stock Forecast | Zelira Therapeutics | - |
4
|
$0.70 | Buy/Sell | $11.70 | -100.00% |
| CCO Stock Forecast | The Calmer Co International | - |
-14
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| CGB Stock Forecast | Cann Global | - |
0
|
$0.02 | Buy/Sell | $0.00 | -100.00% |
Site Navigation
.jpg)